CoChat

MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPC s) via targeting of MMP‐16

Open access
Liu, Jia, van Mil, Alain, Aguor, Eissa N. E., Siddiqi, Sailay, Vrijsen, Krijn, Jaksani, Sridevi, Metz, Corina, Zhao, Jiajun, Strijkers, Gustav J., Doevendans, Pieter A., Sluijter, Joost P. G. · 2012 · Journal of Cellular and Molecular Medicine
Cited by 43

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Abstract

Undesired cell migration after targeted cell transplantation potentially limits beneficial effects for cardiac regeneration. Micro RNA s are known to be involved in several cellular processes, including cell migration. Here, we attempt to reduce human cardiomyocyte progenitor cell (hCMPC) migration via increasing micro RNA‐155 (miR‐155) levels, and investigate the underlying mechanism. Human cardiomyocyte progenitor cells (hCMPC s) were transfected with pre‐miR‐155, anti‐miR‐155 or control‐miR (ctrl‐miR), followed by scratch‐ and transwell‐ assays. These functional assays displayed that miR‐155 over‐expression efficiently inhibited cell migration by 38 ± 3.6% and 59 ± 3.7% respectively. Conditioned medium from miR‐155 transfected cells was collected and zymography analysis showed a significant decrease in MMP‐2 and MMP‐9 activities. The predicted 3′‐UTR of MMP‐16, an activator of MMP‐2 and ‐9, was cloned into the pMIR‐REPORT vector and luciferase assays were performed. Introduction of miR‐155 significantly reduced luciferase activity which could be abolished by cotransfection with anti‐miR‐155 or target site mutagenesis. By using MMP‐16 si RNA to reduce MMP‐16 levels or by using an MMP‐16 blocking antibody, hCMPC migration could be blocked as well. By directly targeting MMP‐16, miR‐155 efficiently inhibits cell migration via a reduction in MMP‐2 and ‐9 activities. Our study shows that miR‐155 might be used to improve local retention of hCMPCs after intramyocardial delivery.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1582-4934.2012.01551.x

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 43

Metadata

Authors
Liu, J., van Mil, A., Aguor, E. N. E., Siddiqi, S., Vrijsen, K., Jaksani, S., Metz, C., Zhao, J., Strijkers, G. J., Doevendans, P. A., & Sluijter, J. P. G.
Venue
Journal of Cellular and Molecular Medicine
Publisher
Wiley
Published
2012-09-26
Volume
16
Issue
10
Pages
2379-2386
ISSN
  • 1582-1838 (ISSN-L)
  • 1582-4934
OpenAlex
W2168959413
Cited by
43
References
2
FWCI
1.51
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPC s) via targeting of MMP‐16. https://app.cochat.ai/papers/10.1111/j.1582-4934.2012.01551.x
The paper
Liu, J., van Mil, A., Aguor, E. N. E., Siddiqi, S., Vrijsen, K., Jaksani, S., Metz, C., Zhao, J., Strijkers, G. J., Doevendans, P. A., & Sluijter, J. P. G. (2012). MiR‐155 inhibits cell migration of human cardiomyocyte progenitor cells (hCMPC s) via targeting of MMP‐16. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/j.1582-4934.2012.01551.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.